Allena Pharmaceuticals Total Liabilities

Allena Pharmaceuticals (ALNA) currently reports a total liabilities of $14M as of June 2022. That compares with $18M in the prior-year period — down 21.9% year over year. Use the charts on this page to explore Allena Pharmaceuticals's total liabilities history and peer comparisons.

Allena Pharmaceuticals's total liabilities decreased from $18M to $14M — a 21.9% year-over-year decrease (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Allena Pharmaceuticals reported $14M in total liabilities as of June 2022. That compares with $18M in the prior-year period — down 21.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Allena Pharmaceuticals, and consider following ALNA for alerts when major investors trade the stock.

Allena Pharmaceuticals is classified in the Healthcare sector. On total liabilities, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALNA with unrelated industries.